ResusX:Podcast

Is the "Cytokine Storm" the Real Killer in ARDS? When a localized lung injury spirals into a systemic catastrophe, we call it a cytokine storm—but are we actually any closer to stopping it, or are we just watching the rain? This deep-dive review, published in the Journal of Intensive Medicine, synthesizes decades of mechanistic research and clinical trials to map how dysregulated immune pathways bridge the gap between respiratory failure and multiorgan dysfunction syndrome (MODS). The authors break down the biological chaos of ARDS into two distinct camps: the hyperinflammatory and hypoinflammatory subphenotypes. While the former is defined by a "reactive" profile of elevated IL-6, IL-8, and sTNFr-1, it’s not just about the numbers; it’s about the "so what" at the bedside. These profiles dictate who survives, who stays on the vent, and critically, who actually responds to interventions like higher PEEP or corticosteroids. We move beyond standard supportive care to explore the cutting edge of precision medicine. From the established success of the DEXA-ARDS trial to the emerging potential of cytokine nanosponges and MSC-derived extracellular vesicles, this episode explores how we can shift from "one-size-fits-all" ventilation to biomarker-guided, disease-modifying therapy. Ready to move past the Berlin Definition and into the era of personalized intensive care? Tune in as we untangle the storm.

Can we break the cycle of Diuretic Resistance? What do you do when the "gold standard" treatment for your congested patient simply stops working? Diuretic resistance (DR) affects up to one-third of patients with heart failure, turning a routine clinical task into a high-stakes battle against prolonged hospitalization and mortality. In this episode, we dive into a comprehensive narrative review that moves beyond simple drug escalation to offer a sophisticated, phenotype-driven roadmap for the modern clinician. The authors synthesize data from nearly 100 pivotal studies to dismantle the "one-size-fits-all" approach to decongestion. We explore the multifactorial drivers of resistance—from chloride depletion and neurohormonal "braking" to the structural remodeling of the nephron itself. Rather than just pushing more furosemide, the study highlights how early monitoring of urinary sodium and the use of point-of-care ultrasound (POCUS) can identify failure before it becomes entrenched. The real "so what" for your next shift lies in the study’s focus on four challenging phenotypes: Right Heart Failure, advanced CKD, Obesity, and Frailty. We discuss why chloride repletion might be your secret weapon, how metabolic therapies like GLP-1 RAs are changing the game for obese patients, and why a small rise in creatinine shouldn't always scare you away from aggressive diuresis. Tune in to learn how to tailor your decongestion strategy to the patient in front of you and finally get ahead of the curve on diuretic resistance.

Sepsis and Coagulation: Is It Time to Put the Heparin Away? Is "thinning the blood" the missing piece in the sepsis puzzle, or just a recipe for disaster? Sepsis triggers a deadly cascade of inflammation and clotting, yet the debate over therapeutic anticoagulation has left ICU clinicians caught between the potential for organ salvage and the perilous risk of hemorrhage. In this episode, we break down a 2026 systematic review and meta-analysis from the *Journal of International Medical Research*. The investigators pooled data from 10 major studies—including 8 randomized controlled trials—covering nearly 7,500 adult patients to determine if agents like heparin, antithrombin III, or recombinant thrombomodulin actually save lives. The verdict? We discuss why the data shows that routine anticoagulation in unselected sepsis patients offers **no significant mortality benefit** and trends toward a higher risk of major bleeding. We also unpack a critical discrepancy: while observational studies suggested a survival advantage, the rigorous RCTs flatly contradicted this, exposing the dangers of selection bias. Join us as we explore why the "one-size-fits-all" approach to sepsis anticoagulation is officially dead and why future hopes now rest entirely on high-risk subgroups like those with disseminated intravascular coagulation (DIC). Tune in to get the evidence you need to make safer decisions at the bedside.

Some random musings post shift

Is it time to retire the Bag-Valve-Mask for preoxygenation? Emergency intubation carries a notorious risk of life-threatening hypoxemia, yet the debate on the safest way to build an oxygen reserve continues .  In this episode, we unpack a 2026 systematic review and meta-analysis that challenges the status quo, pitting Noninvasive Ventilation (NIV) directly against standard Bag-Valve-Mask (BVM) ventilation .  We dive into data from three randomized controlled trials involving over 1,500 critically ill adults . The verdict?  NIV emerged as the clear winner for efficacy, significantly slashing the risk of hypoxemia during intubation compared to BVM .  Perhaps even more importantly for the safety-conscious provider, the study busts a persistent myth: NIV demonstrated no significant difference in regurgitation rates compared to BVM, alleviating long-held fears about aspiration risk .  So, what does this mean for your next airway crash?  This evidence suggests NIV offers a superior safety buffer for oxygenation without the feared trade-offs . Tune in as we explore why this procedural switch could be a game-changer for patient safety in the ED and ICU.

A new podcast of just me in my car

Is the reign of "Normal" Saline over, or is the classic bag of salt water actually the hero of the trauma bay? For years, the critical care community has debated whether we should abandon 0.9% sodium chloride in favor of balanced crystalloids like Lactated Ringer’s or Plasma-Lyte to protect the kidneys and prevent acidosis. But a new study suggests we might be writing off saline too soon—especially when the brain is involved.  In this episode, we break down a 2026 systematic review and meta-analysis from the American Journal of Emergency Medicine .  The researchers pooled data from six randomized controlled trials involving nearly 2,000 trauma patients to compare efficacy and safety . The results might surprise proponents of balanced fluids. While there was no significant difference in acute kidney injury or general mortality for non-head trauma, the data revealed a vital signal for Traumatic Brain Injury (TBI).  In TBI patients, Normal Saline was actually associated with lower mortality and more ventilator-free days compared to balanced solutions . So, what does this mean for your next trauma alert?  It suggests that the slight hypertonicity of saline might be protective against cerebral edema, making it a potentially superior choice for head-injured patients . Tune in as we dissect the pathophysiology, the "chloride load" myth, and why Normal Saline remains a safe, standard option for undifferentiated trauma resuscitation.

Is Ketamine really the "hemodynamically stable" hero of airway management, or have we been unfairly vilifying Etomidate for decades? The debate over the perfect induction agent for critically ill patients just got a major influx of data that flips conventional wisdom on its head .   In this episode, we break down the landmark "RSI" trial, a massive multicenter randomized controlled study involving over 2,300 critically ill adults in EDs and ICUs across the US .  The headline results are a shocker: Ketamine did not reduce 28-day mortality compared to Etomidate . Even more surprising? The "hemodynamically neutral" reputation of Ketamine took a hit.  Patients randomized to Ketamine actually experienced significantly higher rates of cardiovascular collapse—including hypotension and increased vasopressor needs—during intubation compared to those receiving Etomidate .   We unpack what this means for your next shift: why the theoretical fears of Etomidate-induced adrenal suppression didn't translate to patient harm, and why Ketamine might be less forgiving in shock states than we previously thought . Tune in as we dissect the data and discuss whether it’s time to stop hesitating and reach for the Etomidate.

Is the "best of both worlds" actually saving lungs, or just complicating care?  Theoretically, combining the powerful pressure support of Non-Invasive Ventilation (NIV) with the comfort and washout mechanisms of High-Flow Nasal Cannula (HFNC) sounds like the ultimate strategy to prevent intubation . But does this physiological synergy actually translate to patient survival?  In this episode, we break down a new meta-analysis from the American Journal of Emergency Medicine that pooled data from six RCTs and over 700 adults with Acute Respiratory Failure (ARF) .   The researchers investigated whether alternating or combining these devices as an initial strategy is superior to using just one alone .  The headline result might surprise you: the study found no significant reduction in intubation rates or mortality compared to monotherapy .  However, don't write off the combo just yet—the devil is in the details.  We explore a fascinating data split where the efficacy of the combination hinged entirely on lung-protective strategies .  We discuss why unchecked tidal volumes during NIV might be masking the benefits of the combination, leading to ventilator-induced lung injury (VILI) .  Tune in for a critical look at why "more support" isn't always "smarter support," and how to identify the specific patients who might still benefit from this tag-team approach .

For decades, a single dogma has ruled neurotrauma resuscitation: Never use ketamine in TBI. The historical fear that ketamine spikes intracranial pressure (ICP) has kept one of the most versatile, hemodynamically friendly induction agents on the shelf—but is that fear based on fact or outdated physiology?     In this episode, we dissect a massive 2026 systematic review and meta-analysis from the Journal of Critical Care .  By analyzing over 6,000 patients across 15 studies—including four RCTs and strictly post-2015 data—this paper puts the "old myth" to the ultimate test .  We break down how the researchers compared ketamine against other agents like propofol and etomidate to evaluate hospital mortality, ICP crises, and adverse events in both adult and pediatric populations .  The findings are practice-changing.  The data reveals zero association between ketamine use and ICP spikes or increased mortality, effectively debunking the classic contraindication .  However, the review uncovers a controversial "plot twist": a potential link to hypotension that challenges our assumptions about ketamine's stability in catecholamine-depleted trauma patients .   Tune in as we analyze the "study dominance bias" that complicates these hemodynamic results and discuss exactly how this evidence should reshape your airway strategy for the severe TBI patient .

In this episode, we tackle one of the most persistent questions in perioperative care: how low is too low when it comes to hemoglobin in high-risk cardiac patients after major surgery? The long-standing restrictive threshold of 7 g/dL has been considered safe for years, but the TOP Trial challenges that comfort zone. More than 1,400 high-risk veterans were randomized to either a liberal transfusion strategy (Hgb <10 g/dL) or a restrictive one (Hgb <7 g/dL). The primary outcome showed no significant difference in death or major ischemic events. That part was expected. The surprise came in the secondary outcomes. Patients in the restrictive group had nearly double the rate of non-fatal cardiac complications, including new heart failure and dangerous arrhythmias. The liberal strategy cut those complications by almost 40 percent. This episode breaks down what these findings mean for real-world practice, how they challenge current transfusion guidelines, and when you might reconsider your trigger for your most vulnerable post-op patients. If you take care of surgical patients with cardiac risk, this is an episode you cannot skip.

Can a Single Word Change the Culture of an ICU? Burnout is an epidemic in our Intensive Care Units, affecting staff well-being, patient care, and even hospital costs. But what if the solution to this widespread problem was simpler than we think? This week, we’re diving into the Hello Trial, a massive 1:1 cluster-randomized controlled trial conducted across 370 ICUs in 60 countries. Researchers tested a simple, four-week, unit-based intervention designed to promote positive workplace culture and within-team support using tools like posters, email nudges, positive message boxes, and role modeling. The results are practice-changing: The intervention significantly reduced burnout prevalence from 63.3% in the control group to 52.2% in the intervention group (P < 0.001). It improved perceptions of job satisfaction, workplace safety, ethical climate, and patient- and family-centered care. Staff in the intervention arm were less likely to consider changing jobs. They also had lower emotional exhaustion, lower depersonalization, and higher personal accomplishment scores. Here’s the bedside “so what”: A pragmatic, system-level focus on positive communication and team cohesion can rapidly and meaningfully shift your unit’s culture—directly improving staff well-being. Forget the individual-focused, time-draining wellness programs. The answer might be in a simple, collective shift in how we interact. Tune in as we break down the specific components of the Hello intervention and how you can bring this powerful, low-cost strategy to your ICU.

For decades, we’ve been told vasopressors belong only through central lines — but what if that’s not the whole story? In this episode, we unpack a groundbreaking multicenter study from Addis Ababa that dares to challenge convention. Researchers followed 250 patients in shock, tracking survival outcomes, complications, and safety when vasopressors were given peripherally instead of through central access. The result? A strikingly low extravasation rate of just 1.2%, with all complications occurring only after five days of infusion. For short-term management, the data suggests — peripheral might be not only feasible, but safe. We’ll explore what this means for critical care teams everywhere — especially in resource-limited settings where central access isn’t always an option. Is it time to rewrite the playbook for shock management? What are the risks, the predictors of survival, and the real-world tradeoffs? Tune in as we dig into the data, the debates, and the bedside lessons from this landmark study — and ask the question every critical care clinician should be thinking about: Are we overcomplicating vasopressor delivery? Science meets practicality. Evidence meets the frontline. And the future of shock resuscitation might just look a little different.

Why are we still arguing about the best way to give fluids to patients with traumatic brain injury (TBI)? 🤔 This seems like a basic question, but the answer is complex and could mean the difference between life and death at the bedside. A recent comprehensive review article from the Journal of Clinical Medicine dives deep into the clinical and physiological challenges of fluid resuscitation in TBI patients. The authors conducted a non-systematic literature review of studies over the last two decades, focusing on fluid management, types of fluids, and transfusion strategies. The research highlights a critical paradox: while hypotension (low blood pressure) is a known killer in TBI, giving too much fluid can be just as deadly by worsening cerebral edema.                   The key takeaway? There is no one-size-fits-all approach. For fluid choice, the review argues against using balanced crystalloids like Ringer's lactate, suggesting they could worsen cerebral edema due to their relative hypotonicity. Instead, normal saline is often the preferred first-line fluid . As for blood transfusions, the data is contradictory. While some studies suggest a liberal transfusion strategy (aiming for a higher hemoglobin target) improves outcomes, others found no benefit and even a higher risk of adverse events    . This means that transfusion decisions should be highly individualized, based on the patient's specific physiological parameters, not a fixed number    .  This research is a wake-up call for frontline clinicians. It reminds us that blindly following protocols can be harmful. Every fluid bag, every pressor drip, and every unit of blood must be a thoughtful, personalized decision guided by robust hemodynamic and neuromonitoring .  Want to know how to make smarter, more precise fluid decisions for your TBI patients? Tune in to this episode as we break down the latest evidence and translate it into actionable steps for your daily practice.

Are we giving our older patients with out-of-hospital cardiac arrest (OHCA) a fair shot? ⏱️ Current guidelines say an ECPR initiation time of up to 60 minutes is acceptable, but is that really the case for everyone? This is a question clinicians grapple with every day at the bedside. A new nationwide observational study from South Korea tackles this head-on, analyzing data from 483 adult patients who received ECPR for non-traumatic OHCA. The study found that while both age and time to ECPR independently predict survival, the combination of the two is critical. The key takeaway? The "golden hour" for ECPR may not apply to our elderly patients. The results are practice-changing and frankly, a wake-up call. The study found that in patients over 65, the probability of survival plummeted to less than 10% when ECPR was delayed beyond just 21 minutes. For their younger counterparts, a 10% survival rate was maintained for nearly twice as long, up to 38 minutes    . This finding suggests that for older patients, the effective window for ECPR is much shorter than previously thought . The authors recommend a sense of urgency, urging clinicians to activate ECPR in carefully selected elderly patients almost immediately upon hospital arrival    .  This isn't just about a new number; it's about re-evaluating our clinical protocols and embracing an age-specific approach to resuscitation. Tune in as we break down the data and discuss what this means for your next OHCA case.

When it comes to saving lives in the ICU, every breath counts. But what’s the best way to deliver that breath—pressure-controlled ventilation (PCV) or volume-controlled ventilation (VCV)? In this episode, we dive into a new systematic review and meta-analysis that put these two ventilator modes head-to-head in over 1,100 patients with acute respiratory failure. The findings may surprise you: while both modes showed no major differences in barotrauma or overall mortality, PCV hinted at a slight edge in reducing deaths among patients with ARDS. What does this mean for frontline clinicians? Could PCV be the more patient-friendly option when seconds matter? Join us as we unpack the data, discuss the implications for practice, and explore where future research needs to go. Tune in for a deep dive into ventilator strategies that could shape critical care worldwide.

When a patient crashes with acute cardiogenic pulmonary edema, emergency teams need fast, effective solutions. For years, non-invasive ventilation (NIV) has been the gold standard — but could high-flow nasal cannula (HFNC) be just as good? In this episode, we break down a prospective, randomized trial published in the American Journal of Emergency Medicine (Dec 2025) that compared HFNC head-to-head with NIV in the ED. The results? No difference in survival, respiratory rates, or dyspnea scores between the two therapies. We’ll explore: Why HFNC may rival NIV for managing ACPE The surprising equivalence in clinical outcomes at 30, 60, and 120 minutes Patient comfort and tolerability — where HFNC may hold the edge What this means for ED practice, protocols, and future airway management If you’re an emergency physician, intensivist, or resuscitationist, this study has big implications: it suggests you may have more flexibility — and your patients, more comfort — than ever before.

When a patient is crashing and every second counts, airway decisions can mean life or death. For decades, clinicians have fiercely debated: should you reach for etomidate, the hemodynamic workhorse, or ketamine, the pressure-friendly multitasker? In this episode, we dive deep into a new systematic review and meta-analysis that just might end the controversy once and for all. The surprising truth? Survival doesn’t change no matter which drug you choose. We’ll unpack: Why this finding is a game-changer for emergency physicians, intensivists, and resuscitationists. What the evidence really says about mortality, intubation success, and cardiac arrest risk. The nuances of post-induction hypotension and why it might not be the dealbreaker it once seemed. How this study frees you to make airway decisions based on patient context and clinical judgment—not dogma. Whether you’re on the front lines of the ED, running codes in the ICU, or training the next generation of airway masters, this episode will leave you with clarity, confidence, and a renewed perspective on one of emergency medicine’s longest-running debates.

When major abdominal surgery pushes patients to the brink, timing is everything, especially with norepinephrine. Could giving it earlier to high-risk patients prevent dangerous drops in blood pressure and reduce complications? A new randomized controlled trial, published in Anesthesiology (2025), put this to the test, comparing early, low-dose norepinephrine infusion against standard care in high-risk surgical patients. The results may surprise you: early norepinephrine not only stabilized blood pressure faster but also significantly reduced postoperative complications without increasing adverse events. In this episode, we break down what “early” really means, why the trial’s pragmatic design matters, and how this could reshape perioperative hemodynamic management in major surgery. Key takeaways: • Early norepinephrine led to more stable intraoperative blood pressure • Reduced risk of postoperative complications in high-risk patients • No significant increase in adverse events compared to standard care This isn’t just about drugs, it’s about redefining timing in critical surgical care. Want to dig deeper? Check out the full study: Trocheris-Fumery O, Flet T, Scetbon C, et al. Early Use of Norepinephrine in High-Risk Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial. Anesthesiology. 2025. doi:10.1097/ALN.0000000000005704

When it comes to getting patients off mechanical ventilation, clinical judgment isn’t always enough. What if you could use a real-time, bedside tool to boost your confidence—and your success rate? In this episode, we dive into the power of diaphragmatic ultrasound in predicting successful weaning from mechanical ventilation. Based on the latest meta-analysis, we break down how measuring diaphragm function—like excursion and thickening fraction—can provide moderate-to-high diagnostic accuracy in identifying who’s ready to breathe on their own. Find out: Why traditional predictors aren’t cutting it What makes diaphragmatic ultrasound a game-changer And whether this tool should become your new go-to in the ICU Based on the article of Tashiro, N., Nishiwaki, H., Ikeda, T. et al. titled "Clinical utility of diaphragmatic ultrasound for mechanical ventilator liberation in adults: a systematic review and meta-analysis" from j Intensive Care.

Can IV vitamin C really save lives in the PICU? It’s been a hot topic in critical care circles for years—but the VITACIPS trial just delivered a powerful dose of clarity. In this episode, we dive into the results of this rigorous study and what they mean for treating children in septic shock. Spoiler: it’s not the magic bullet many hoped for. We break down key findings, clinical implications, and why this trial is a turning point in how we think about adjunct therapies in pediatrics. Whether you're treating pediatric patients or just curious about how cutting-edge research shapes real-world care, this one’s worth the listen. Based on the article: “Vitamin C Versus Placebo in Pediatric Septic Shock (VITACIPS) – A Randomised Controlled Trial” by Jhuma Sankar et al., Journal of Intensive Care Medicine.

What happens when a patient in the ICU suddenly can't breathe—and the usual airway tools just won’t cut it? In this episode, we break down the high-stakes world of difficult airway management where seconds matter and lives hang in the balance. From using checklists like LEMON to deploying advanced gear like video laryngoscopes and rescue devices, this isn’t just medicine—it’s a strategic, lifesaving playbook in action. We explore the latest evidence, essential algorithms, and game-changing tools that are helping clinicians stay calm, stay sharp, and save lives when the pressure is highest. Whether you're on the frontlines or just curious how modern medicine handles its toughest challenges, this is an episode you don’t want to miss. Based on the article: “Difficult Airway Management in the Intensive Care Unit: A Narrative Review of Algorithms and Strategies” by Talha Liaqat et al., Journal of Clinical Medicine.

When seconds count and precision matters—like during surgery—getting accurate, continuous blood pressure readings is critical. That’s where radial artery cannulation comes in. But while traditional methods rely on “feeling the pulse,” they’re not always reliable, especially in tough cases. Enter a game-changing technique: ultrasound-guided Dynamic Needle Tip Positioning (DNTP). In this episode, we dive into a powerful new study that compares old-school palpation to DNTP and the results are stunning: an 88.5% first-pass success rate, fewer attempts, less time, and reduced equipment use with the ultrasound approach. We explore why this matters for patient safety, comfort, and clinical efficiency—and how this could redefine arterial cannulation in the OR. Could this be the new gold standard for arterial access? Tune in and find out. Read the full study: "Palpation versus Ultrasound-Guided Dynamic Needle Tip Positioning Technique for Radial Artery Cannulation" by Sujan Dhakal et al. in Annals of Cardiac Anaesthesia.

When someone is critically ill, whether battling sepsis, ARDS, or severe pneumonia, corticosteroids have long been a debated topic. A massive new meta-analysis pooling data from over 10,000 ICU patients finally brings clarity. The headline: early, low-dose, prolonged steroid therapy cuts short-term mortality by roughly 15%, slashes ICU stays by 2 days, reduces time on ventilators by over 4 days, and boosts ventilator-free days—all without increasing infection or bleeding risks. Sure, there’s a slight uptick in hyperglycemia, but that’s a small price for improved survival and recovery  What does this mean for frontline clinicians? Think “early, gentle, and sustained.” Start steroids within the first 72 hours, keep them on for at least a week, and tailor doses to lower than 400 mg of hydrocortisone per day. Most surprisingly, even septic shock patients benefit most when hydrocortisone is paired with fludrocortisone Want to see the full picture? Check out the study: “Efficacy and safety of corticosteroids in critically ill patients” by Lei Cao et al. in BMC Anesthesiology (July 2025).

When seconds count in the ICU, the IV fluid you choose could literally make or break a patient’s recovery. In this episode, we’re unpacking one of the biggest debates in critical care: balanced crystalloids vs. normal saline. A massive new meta-analysis of over 35,000 patients drops a game-changing truth—your fluid choice must depend on whether the patient has a traumatic brain injury (TBI). Balanced solutions may lower mortality in most critically ill patients, but for those with TBI, they could actually do harm. Tune in to hear how this data is flipping standard practice on its head and pushing the ICU world toward smarter, personalized resuscitation. Want to dive deeper? Check out the full study “Effect of Treatment With Balanced Crystalloids Versus Normal Saline on the Mortality of Critically Ill Patients With and Without Traumatic Brain Injury” by José C. Diz et al. in Critical Care and Resuscitation.

In today’s episode, we’re diving into a game-changing question: Can swapping fentanyl for remifentanil help ventilated ICU patients breathe on their own sooner, and with fewer complications like delirium? This fresh meta-analysis pulls data from multiple studies and suggests remifentanil could reduce ventilation time by up to 21 hours in some cases and may lower the risk of ICU-related delirium. While the evidence is still growing and more rigorous trials are needed, the findings raise big questions about how we manage pain and recovery in critical care. Tune in for key takeaways, clinical implications, and what this could mean for the future of ICU sedation. Want to go deeper? Read the full study: "Comparative efficacy of remifentanil and fentanyl in mechanically ventilated ICU patients: a systematic review and meta-analysis on ventilation duration and delirium incidence" by Hiromu Okano et al. in Journal of Anesthesia, Analgesia and Critical Care.

When it comes to oxygen therapy for critically ill, ventilated patients, more isn’t always better—but is less the answer? The UK-ROX trial set out to find out, tracking over 16,000 ICU patients across 97 hospitals to test if targeting lower oxygen saturation (SpO₂ ~90%) could improve survival rates. Spoiler alert: it didn’t. In this episode, we unpack why conservative oxygen therapy didn’t significantly impact 90-day mortality—and what that means for frontline ICU care today. With no meaningful differences in mortality, ICU stays, or days free from organ support, the results suggest that “usual care” oxygen strategies may already be doing the job. Key takeaways: • Conservative O₂ therapy didn’t improve survival • 90-day mortality nearly identical across groups • Usual care remains a safe and effective standard Breathe easy—this episode cuts through the noise and gives you the real clinical takeaways. Want to dig deeper? Check out the full study: "Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients" by Daniel S. Martin et al., published in JAMA.

Can Ultrasound Save Lives in Septic Shock? Septic shock is a race against time, and now, there's a powerful new tool at the bedside. A recent meta-analysis of nearly 4,000 ICU patients reveals that using point-of-care echocardiography (POC echo) to guide treatment slashes mortality rates by up to 18%. In this episode, we dive into how this quick bedside ultrasound isn't just helping docs see more—it’s changing decisions, improving outcomes, and getting organs back on track faster. From better inotropic support to quicker lactate clearance, POC echo might just be the new game-changer in critical care. Tune in and learn how this visual tool could be the lifeline in septic shock. Want the full breakdown? Check out “The association between integrating echocardiography use in the management of septic shock patients and outcomes in the intensive care unit” by Keith Killu et al., in the Journal of Ultrasound (2025). #CriticalCare #SepticShock #POCecho #UltrasoundInICU #ResusTalks #ICUpodcast #EmergencyMedicine #SepsisAwareness

Restarting the heart is only half the fight—what comes next could make or break recovery. In this episode, we dive into the high-stakes world of post-resuscitation shock and a game-changing debate: epinephrine or norepinephrine? New data from over 3,400 patients suggests norepi might dramatically cut the risk of a second cardiac arrest—by 63%! That’s huge. But does it impact survival? Brain function? Tune in as we unpack the numbers, the controversy, and what it all means for your resus playbook. Want more details? Check out the full study "Norepinephrine versus epinephrine after cardiac arrest: A systematic review and meta-analysis" by Caitlin A. Williams et al. in the American Journal of Emergency Medicine.

In this podcast episode, resus pros Swami, Mike, and Steve go head-to-head on the hottest controversies in emergency and critical care medicine. From the great bougie vs. stylet debate to the ethics of prehospital whole blood and the eternal neuro RSI paralytic showdown — nothing is off-limits. We talk: Bougie every time? Or nah? Should every ambulance carry blood? Succinylcholine vs. rocuronium for neuro patients How to train airway newbies — VL or DL first? Whether you’re an airway nerd, trauma junkie, or just love good old-fashioned resus banter, this episode delivers clinical pearls with a side of attitude. Grab your stopwatch — the clock is ticking! Tune in now, and don’t forget to bring your strong opinions.

In out-of-hospital cardiac arrest, time is life, and the race to restore circulation is on. But what's faster or better: intravenous (IV) or intraosseous (IO) access? A new study puts this long-standing debate to the test—and the results may surprise you. In this episode, we break down the findings from nearly 1,500 cardiac arrest cases. Spoiler: the data suggests it's not how you get access that matters—it's that you start resuscitation fast. Tune in to find out why this could streamline emergency protocols and change how we approach prehospital care. Study: Intraosseous vs. Intravenous Access during Out-of-hospital Cardiac Arrest by Vallentin et al., Resuscitation Hit play for critical insights, clinical takeaways, and what it means for front-line care. #Resuscitation #CardiacArrest #EmergencyMedicine #Paramedics #IVaccess #IOaccess #PrehospitalCare #ROSC #Podcast

You’ve given fluids, started pressors, and checked all the boxes… but your patient isn’t improving. Now what? In this episode of Talking Shift, Dr. Haney Mallemat sits down with Dr. Anand "Swami" Swaminathan to break down one of the most powerful tools in emergency medicine and critical care: The Cognitive Pause. When the usual approach fails, it's time to stop, reassess, and challenge your assumptions before spiraling deeper into the resuscitation rabbit hole. They unpack: When to switch from reflexive to reflective thinking Clues you’re treating the wrong diagnosis How to avoid cognitive traps in septic shock Swami’s go-to checklist during a pause (think: acidosis, adrenal, hypothyroid, occult bleeding, anaphylaxis, calcium, and more) Real-life cases that highlight the importance of a well-timed pause Why Hickam's Dictum > Occam’s Razor in the ED Whether you're new to the resus scene or deep in the ICU trenches, this episode will sharpen your thinking and change how you approach critically ill patients. Listen now and give your clinical brain the reboot it needs.

We talk a lot about shockable rhythms—but what about asystole? This episode dives into a global meta-analysis of over 540,000 OHCA cases and the results are rough: just 1.5% survive when asystole is the first rhythm. We break down what this means for EMS, why TOR guidelines matter more than ever, and how we need to rethink the resus game when the rhythm is flatline from the start. Based on the study by Dwivedi et al. in Resuscitation: Incidence and outcomes of out-of-hospital cardiac arrest from initial asystole.

Welcome to the Morning Report—your new go-to for raw, unfiltered clinical talk. In this first episode, Dr. Haney Mallemat teams up with legends Dr. Steve Haywood, Dr. Anand Swaminathan, and Mike Abernethy to break down a wild PE case that spirals from EMS to the ED. Here’s what’s coming in hot: ⚡ Pressor stacking IRL: What, when, how? ⚡ Inhaled nitro… hero move or hype? ⚡ TPA—push it fast or slow roll? ⚡ Why intubating a crashing PE can be deadly (and how to avoid it) And we don’t stop there—we’re throwing down some 🔥 rapid-fire takes: Bougie every time or chill out already? Is EMS ready for blood in the field? Roc vs. Succ—who you reppin’ for neuro RSI? What actually works for intubation training in 2025? This episode is fast, fun, a little chaotic—in the best way—and packed with legit pearls for your next resus. 🎟️ Want more? Meet us at ResusX this fall → ResusX.com

In this episode, we’re diving into the latest research on hydrocortisone use in critically ill patients with severe community-acquired pneumonia (CAP). It's a treatment many clinicians reach for—but does it actually make a difference in survival? According to a new study, the answer might not be as strong as we hoped. While hydrocortisone may help shorten the duration of vasopressor support, it doesn’t significantly reduce mortality. We break down what this means for clinical practice, patient care, and the future of treating severe pneumonia. Tune in for key takeaways and why more research is still needed before we rewrite the playbook.

In this episode, we dive into a recent open-label randomized controlled trial on the adjuvant use of midodrine in patients with septic shock. Researchers investigated whether adding midodrine to norepinephrine therapy could improve survival rates. The findings? Midodrine reduced the need for vasopressors, but did not significantly lower 28-day in-hospital mortality or shorten hospital stays. While midodrine showed some impact on reducing vasopressor requirements, its effect on overall outcomes remains limited. Tune in for a quick breakdown of what this means for ICU practice and managing septic shock patients.

In this episode, we look at the latest study on haloperidol for ICU delirium from the New England Journal of Medicine. While haloperidol didn’t increase days alive and out of the hospital, it did show a lower risk of death—a finding that could influence how we approach treatment. Tune in for a quick breakdown of what this means for ICU care and future directions in managing delirium.

In this episode, we break down the ANNEXA-I randomized trial, which looked at patients with factor Xa inhibitor-associated intracerebral hemorrhage. The study compared andexanet alfa, a targeted reversal agent, with usual care (mainly prothrombin complex concentrate). The results? Andexanet showed better hemostatic control and more effectively reduced hematoma expansion (67% vs. 53.1%), with a 94.5% median drop in anti-factor Xa activity. But the benefit came with a trade-off—higher rates of thrombotic events, particularly ischemic stroke. We dive into the clinical implications of these findings and what they mean for balancing bleeding control with thrombotic risk. Whether you're managing ICH cases or staying updated on anticoagulation reversal strategies, this one’s for you.

In this episode of 'Talking Shift,' the host welcomes Dr. Chris Doty, an important figure in emergency medicine, to discuss his journey and the current state of the specialty. Dr. Doty reflects on a crisis from two years ago where a significant number of emergency medicine residency spots went unmatched, but more recent data shows improvement. They explore changes in residency program requirements, particularly the potential shift from three-year to four-year programs, and the implications of such modifications. The conversation also touches on the impact of the pandemic on the perception and reality of working in emergency medicine, the financial pressures of medical education, and the trend towards shorter, more manageable training periods. Additionally, they discuss fellowships, emerging trends, and the critical issue of burnout, especially highlighted during the pandemic. Dr. Doty emphasizes the importance of choosing the right residency program and the vital need for systemic changes to support healthcare professionals better.

In this inaugural episode of 'Talking Shift,' we dive deep into the complex world of managing refractory hypoxemia and ventilator settings with special guest Nick Ghionne, aka @PulmToilet. Explore strategies for optimizing ventilator parameters, understanding the role of driving pressure, effective use of PEEP, and the critical benefits of proning. We also discuss the nuanced use of adjuncts like nitric oxide and epoprostenol. Learn practical tips for real-life scenarios, ensuring better patient outcomes in critical care. Tune in to gain invaluable insights from two experts and elevate your critical care expertise!

Let’s talk about saving two hearts at once this Valentine's Day. Get 20% off and access the full ResusX: ReUnion conference—featuring this episode and over 60 expert-led lectures available for lifetime replay: Click Here. In this episode, Dr. Shaila Quazi demystifies resuscitative hysterotomy, the life-saving procedure formerly known as the perimortem C-section. Learn when to act, how to assemble the right teams, and the step-by-step approach that can maximize survival for both mother and baby. Packed with practical mnemonics, real-world cases, and expert insights, this is a must-listen for anyone in emergency or critical care medicine. Because nothing says “I care” more than being ready to save lives. 

Is dual sequential defibrillation (DSED) the key to saving shock-refractory VFib patients? Get 20% off and access the full ResusX: ReUnion conference—featuring this episode and over 60 expert-led lectures available for lifetime replay: Click Here. In this episode, Dr. Tarlan Hedayati takes a deep dive into the history, science, and best practices for dual defibrillation. She explains why vector change and dual sequential shocks may improve outcomes in refractory VFib, how to properly time and place pads, and what the latest DOSE-VF trial tells us about neurological survival rates. If you manage cardiac arrests, this episode delivers game-changing insights into the future of defibrillation!

What should you really be looking for in a post-arrest ECG? In this episode, Dr. Amal Mattu unpacks the hidden dangers of misinterpreting early post-resuscitation ECGs and how making the wrong call on VTach mimics could be fatal. Learn when to repeat the ECG, when to send patients for cath, and how to recognize life-threatening hyperkalemia or sodium channel toxicity masquerading as VTach. Packed with real cases and expert insights, this episode is a must-listen for anyone managing post-cardiac arrest care!

What happens when you need to intubate a patient, but their airway is filled with vomit, blood, or thick secretions? In this episode, Dr. Shyam Murali takes us through the SALAD (Suction-Assisted Laryngoscopy and Airway Decontamination) technique, a life-saving approach to managing contaminated airways. Learn how to optimize suction, clear the airway, and improve intubation success with game-changing strategies like the suction park and SALAD poke methods. If you’re in emergency or critical care medicine, this episode is packed with must-know airway management skills that could save a life!

How do you manage a patient with status epilepticus when every second counts? In this episode, Dr. Derek Isenberg outlines a step-by-step algorithm for seizure management, emphasizing high-dose benzodiazepines, evidence-based second-line agents, and the growing role of ketamine for refractory seizures. Learn why time is critical, how to identify non-convulsive status with continuous EEG, and how aggressive early intervention can make all the difference. Tune in to sharpen your seizure management skills and bring cutting-edge care to your practice!

Is it safe to administer 3% hypertonic saline through a peripheral IV during a neurologic emergency? In this episode, Dr. Salim Rezaie breaks down the evidence and challenges the need for central lines in time-sensitive cases. Learn why bolusing hypertonic saline through a peripheral line can reduce intracranial pressure more effectively while avoiding delays and central line complications. Packed with data and practical insights, this discussion is essential for anyone managing critical care patients. Don’t miss this thought-provoking episode on advancing emergency medicine!

What is auto-PEEP, and why can it lead to life-threatening complications in ventilated patients? In this episode, Dr. Anozie breaks down the physiology behind auto-PEEP, its dangerous effects like dynamic hyperinflation and cardiovascular instability, and how to spot its subtle signs on ventilator waveforms. With a focus on practical solutions, from adjusting ventilator settings to optimizing PEEP, this episode equips you with the knowledge to protect your patients and save lives. Don’t miss this vital discussion on ventilator management and critical care!

What do you do when a patient in shock doesn’t respond to vasopressors? In this episode, Dr. Anand Swaminathan dives into the art of the ‘cognitive pause’—a crucial step in troubleshooting refractory shock. From acidosis and hypothyroidism to occult bleeding and adrenal insufficiency, he outlines a systematic approach to uncover hidden causes that could change the course of care. If you’re ready to sharpen your resuscitation skills and tackle the toughest cases, this episode is for you!

Looking to master the nuances of Airway Pressure Release Ventilation (APRV)? In this episode, Dr. Steven Haywood simplifies APRV, from setup to weaning, while uncovering the secrets to maximizing lung recruitment and oxygenation. Whether you’re optimizing care for ARDS patients or learning to avoid pitfalls like overdistension or lost ground during ventilator disconnects, this talk offers actionable strategies for critical care success. Tune in and elevate your understanding of advanced ventilator management!

Handling an unruly trauma patient is one of the greatest challenges in emergency medicine—but it doesn’t have to be. If you’re ready to master resuscitation and learn cutting-edge emergency techniques, get 20% off the ResusX: ReUnion conference—featuring over 60 transformative talks available for lifetime replay: Click Here. In this episode, Dr. Fred Gmora shares his expert insights into managing combative trauma patients. From rapid sedation with ketamine to maintaining spontaneous respirations, he explains how to stabilize patients and keep the trauma bay under control. Whether you’re in the ED or a trauma center, this episode is packed with essential tips to save lives and manage chaos effectively. Don’t miss it! https://www.resusx.com/offers/Uc5kMyCz?coupon_code=REUNION20